Clinical trial
Development of a Breath Test for Monitoring Patients With Liver Disease
NCT00244569 · Virginia Commonwealth University, Other · Completed
Key facts
| NCT number | NCT00244569 |
|---|---|
| Title | Development of a Breath Test for Monitoring Patients With Liver Disease |
| Official title | Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis |
| Lead sponsor | Virginia Commonwealth University, Other |
| Collaborators | Oridion Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fatty Liver, Cirrhosis |
| Intervention type | Device, Drug |
| Interventions | 13C-Methacetin, Breath ID Machine |
| Enrollment | 120 |
| Start date | Sep 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Oct 26, 2005 |
| Last update posted | Mar 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: